0.00 (0.00%) Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2021.
The company has reported a rise of 10.39% in its net profit at Rs 515.43 crore for the quarter under review as compared to Rs 466.92 crore for the same quarter in the previous year. Total income of the company increased by 4.48% at Rs 4075.89 crore for Q3FY22 as compared Rs 3901.34 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported rise of 11.14% in its net profit at Rs 2058.80 crore for the quarter under review as compared to Rs 1852.48 crore for the same quarter in the previous year. Total income of the company increased by 12.50% at Rs 10295.57 crore for Q3FY22 as compared Rs 9151.73 crore for the corresponding quarter previous year.